Neural modulation of immune function

Journal of Neuroimmunology
T L Roszman, W H Brooks


In this report we review our hypotheses and approaches to the study of the relationship between the central nervous and immune systems. Discussed are results pertaining to the modulation of immune parameters resulting from perturbations of the brain employing electrolytic lesions and the neuroleptic 6-hydroxydopamine. Experiments describing the central and peripheral effects of serotonin on in vivo and in vitro immune responses are also discussed.


Dec 1, 1979·Cellular Immunology·H O BesedovskyH H Keller
Jan 1, 1976·The Journal of Clinical Investigation·L T WilliamsR J Lefkowitz
Jan 21, 1972·Science·B Benacerraf, H O McDevitt
Nov 15, 1974·Nature·S Arrenbrecht
Jan 1, 1984·International Journal of Immunopharmacology·K MilesE Chelmicka-Schorr
Sep 21, 1984·Science·T HökfeltM Goldstein
Jan 1, 1983·Annual Review of Immunology·D R GreenR K Gershon
Mar 1, 1983·The Journal of Experimental Medicine·P W AskenaseW Ptak
Jul 1, 1982·Annals of Neurology·W H BrooksW R Markesbery
Aug 5, 1983·Science·H BesedovskyC Honegger
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·H M Shapiro, T B Strom

❮ Previous
Next ❯


Apr 1, 1987·Pharmacology, Biochemistry, and Behavior·U WesselmannD R Harder
Dec 1, 1989·Journal of Neuroimmunology·C de Micco
Aug 1, 1990·Journal of Neuroimmunology·B M Gebhardt, J M Hill
Jun 1, 1993·Journal of Neuroimmunology·L SantambrogioR Dal Toso
May 1, 1990·Immunology Today·D N KhansariR E Faith
Jan 1, 1988·International Journal of Immunopharmacology·D C HendersonJ M Dewdney
Nov 21, 1986·Neuroscience Letters·R M Torack
May 1, 1992·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·H M Brown-Borg, F W Edens
Jan 1, 1990·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M BoranićG Miljenović
Jan 1, 1993·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·L Smejkal-JagarD Pericic
Mar 1, 1988·Brain, Behavior, and Immunity·A D Ado, M M Goldshtein
Jun 21, 1993·Annals of the New York Academy of Sciences·M MihovilovicA D Roses
Jun 18, 1998·Annals of the New York Academy of Sciences·S Reichlin
Jun 1, 1993·Journal of Neuroimmunology·H B SolvasonR N Hiramoto
Jan 1, 1994·Critical Reviews in Biochemistry and Molecular Biology·B M Conti-TronconiM P Protti
Jul 4, 2012·Neurosurgery Clinics of North America·Jacob RuzevickMichael Lim
Jul 4, 2012·Neurosurgery Clinics of North America·Seunggu J HanAndrew T Parsa
Nov 1, 1996·Immunopharmacology and Immunotoxicology·I MunnoG F Megna
Dec 1, 2009·Neurosurgery Clinics of North America·Seunggu J HanMichael Lim
Mar 1, 2001·Stress : the International Journal on the Biology of Stress·M S Harbuz, D S Jessop
Oct 1, 1991·Immunology Today·T RoszmanW Brooks
Feb 1, 1988·The International Journal of Neuroscience·S Yehuda, R L Carasso
Feb 1, 1992·Journal of Neuroscience Research·J A CohenM B Prystowsky
Jan 1, 1988·The International Journal of Neuroscience·C M Blatteis
Apr 1, 1987·The International Journal of Neuroscience·S YehudaY Kalechman
Nov 1, 1994·The American Journal of Physiology·B MarchettiM Bouvier
Sep 6, 2000·Brain, Behavior, and Immunity·J StefuljK Schauenstein
Jan 1, 1987·Journal of Neuroscience Research·L W Thorpe, J R Perez-Polo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here